Drug or treatment
Cobimetinib clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Cobimetinib that are recruiting, at sites in 3 countries (most in United States (2), United Kingdom (1), South Korea (1)). By phase: Phase 2 (3), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Belvarafenib plus cobimetinib for NRAS-mutant advanced or metastatic melanoma | Phase 2 | Seongnam-si, Gyeonggi-do and 9 other locations | Recruiting | Mar 4, 2026 |
| Treatment for high-risk thyroid cancer with BRAF mutation | Phase 2 | Duarte, California | Recruiting | Jun 4, 2024 |
| Combination of vemurafenib and cobimetinib for treating BRAF positive cancers | Phase 2/3 | Belfast and 15 other locations | Recruiting | Mar 14, 2023 |
| Using cobimetinib to treat refractory Langerhans cell histiocytosis and other histiocytic disorders | Phase 2 | Phoenix, Arizona and 11 other locations | Recruiting | Sep 6, 2019 |
All recruiting trials (4)
-
Belvarafenib plus cobimetinib for NRAS-mutant advanced or metastatic melanoma
This trial will test whether taking belvarafenib with cobimetinib can shrink tumors or control disease in adults with NRAS‑mutant advanced or metastatic melanoma.
-
Treatment for high-risk thyroid cancer with BRAF mutation
This study is testing if a combination of two medications can help people with high-risk thyroid cancer that has a specific mutation feel better before they receive radioactive iodine treatment.
-
Combination of vemurafenib and cobimetinib for treating BRAF positive cancers
This study is testing if the combination of vemurafenib and cobimetinib can help adults with different types of cancers that have a specific BRAF mutation.
-
Using cobimetinib to treat refractory Langerhans cell histiocytosis and other histiocytic disorders
This study is testing if a drug called cobimetinib can help people with hard-to-treat Langerhans cell histiocytosis and other similar disorders feel better.
Quick answers
How many clinical trials of Cobimetinib are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), United Kingdom (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.